{"name": "NX Pharmagen",
 "permalink": "nx-pharmagen",
 "crunchbase_url": "http://www.crunchbase.com/company/nx-pharmagen",
 "homepage_url": "http://www.nxpharmagen.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": 4,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": null,
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Fri Apr 12 18:36:59 UTC 2013",
 "updated_at": "Thu May 30 04:10:47 UTC 2013",
 "overview": "\u003Cp\u003ENX PharmaGen\u2019s business model is to acquire, develop, and monetize mature clinical-stage breakthrough technologies. The company\u2019s lead program is a disruptive diagnostic technology, termed the NeXosomeTM Platform, which is designed to yield: \u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$3.5M",
 "funding_rounds":
  [{"round_code": "angel",
    "source_url": "",
    "source_description": "",
    "raised_amount": 3500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": null,
    "funded_day": null,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}